BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2637244)

  • 1. Serum soluble interleukin 2 receptor in patients with IgA nephropathy.
    Yorioka N; Hirabayashi A; Takemasa A; Kanahara K; Takahashi N; Oda H; Joarder ZH; Harada S; Yamakido M
    Hiroshima J Med Sci; 1989 Dec; 38(4):169-71. PubMed ID: 2637244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
    Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
    Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of soluble receptors for interleukin-2 in the serum of patients with rheumatoid arthritis].
    Pavelka K
    Cas Lek Cesk; 1990 Dec; 129(50):1582-5. PubMed ID: 2272075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble interleukin-2 receptor in patients with glomerulonephritis.
    Yorioka N; Hirabayashi A; Kanahara K; Takemasa A; Oda H; Joarder ZH; Yamakido M
    Am J Nephrol; 1990; 10(3):181-5. PubMed ID: 2382679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical use of serum beta-2-microglobulin and fractional beta-2-microglobulin excretion in IgA nephropathy.
    Lai KN; Lai FM; Vallance-Owen J
    Clin Nephrol; 1986 May; 25(5):260-5. PubMed ID: 3522000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.
    Lai KN; Leung JC; Lai FM
    Clin Nephrol; 1988 Dec; 30(6):330-4. PubMed ID: 2977310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of interleukin-2 receptor and disease activity in patients with IgA nephropathy.
    Tomino Y; Ozaki T; Koide H; Takahashi M; Ito K
    J Clin Lab Anal; 1989; 3(6):355-9. PubMed ID: 2482345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of the soluble receptor for interleukin-2 in serum of patients with rheumatoid arthritis.
    Pavelka K
    Czech Med; 1991; 14(3):164-72. PubMed ID: 1807934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of bacterial antigens in immunoglobulin A nephropathy.
    Hirabayashi A; Yorioka N; Oda H; Sekiguchi Y; Kuramoto A; Okushin S; Yamakido M
    Hiroshima J Med Sci; 1996 Dec; 45(4):113-7. PubMed ID: 9119709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between intestinal permeability and antibodies against food antigens in IgA nephropathy].
    Kovács T; Mette H; Per B; Kun L; Schmelczer M; Barta J; Jean-Claude D; Nagy J
    Orv Hetil; 1996 Jan; 137(2):65-9. PubMed ID: 8721870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of complement 3 receptors (CR1 and CR3) on neutrophils and erythrocytes in patients with IgA nephropathy.
    Tao K; Nicholls K; Rockman S; Kincaid-Smith P
    Clin Nephrol; 1989 Nov; 32(5):203-8. PubMed ID: 2684457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
    Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
    J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of soluble Fas and disease activity in patients with IgA nephropathy.
    Shou I; Tashiro K; Kurusu A; Kaneko S; Hayashi T; Fukui M; Shirato I; Kubota K; Tomino Y
    Nephron; 1999; 81(4):387-92. PubMed ID: 10095173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food antigens, IgA-immune complexes and IgA mesangial nephropathy.
    Fornasieri A; Sinico RA; Maldifassi P; Paterna L; Benuzzi S; Colasanti G; D'Amico G
    Nephrol Dial Transplant; 1988; 3(6):738-43. PubMed ID: 3147415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
    J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).
    Sinico RA; Fornasieri A; Oreni N; Benuzzi S; D'Amico G
    J Immunol; 1986 Jul; 137(2):536-41. PubMed ID: 3722816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X; An H; Jiang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased concentration of serum IgA antibody to pneumococcal polysaccharides in patients with IgA nephropathy.
    Drew PA; Nieuwhof WN; Clarkson AR; Woodroffe AJ
    Clin Exp Immunol; 1987 Jan; 67(1):124-9. PubMed ID: 3497740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.